1999 · 76 citations · 0 references
PharmacyEnvironmental SciencesToxicologyEnvironmental ToxicologyRegulatory ToxicologyRisk AssessmentAnimal Product SafetyExposure AssessmentHealth Risk AssessmentSafety EvaluationToxicity Risk AssessmentToxicology AssessmentAnimal Exposure AssessmentDrug Product IdentificationEnvironmental Safety AssessmentEvaluationIngredient Safety AssessmentSafety Assessment MethodologyToxicity AssessmentToxicologic Risk Assessment
The EC has issued directives (1981, 1992) requesting for registration of veterinary medicinal product information to enable an assessment of the product's safety for the environment. As a whole, the risk assessment is structured around the hazard quotient approach used in USES (1994). Predicted environmental concentrations are compared with effect values established in toxicity studies. In the a risk assessment methodology presented in directive 81/852/EEC the assessment process is described in two phases. The first phase (I) shall assess the potential of exposure of the environment to the product, its ingredients, or relevant metabolites. The first phase is thus limited to product identification and exposure assessment. Several exemptions for further testing are given, such as trigger values for predicted environmental concentrations (PECs). When these exemptions fail to apply and trigger values are exceeded, Phase II is entered. Phase II is also divided in two parts, Tier A and Tier B. Tier A begins with an elaborate evaluation of the possible fate and effects. If the applicant is unable to demonstrate that exposure is minimised to a level of no concern to the environment, then the effects in the relevant compartments must be adequately investigated in Tier B. The Tier B evaluation is subject to expert judgement and is beyond the scope of this document.